Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension study of letrozole or fadrozole in advanced breast cancer
NCT00247663Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 1999
- Primary completion
- Dec 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in breast cancer, sponsored by Novartis. Started Dec 1999; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00247663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00247663.